Palynziq
Payments companies reported to CMS as associated with Palynziq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Palynziq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Palynziq
These are the largest totals companies reported as associated with Palynziq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Elisheva Ellenberg | Detroit, MI | Family | $124,168.96 |
| Barbara Burton | Chicago, IL | Clinical Genetics (M.D.) | $80,371.35 |
| Cary Harding | Portland, OR | Clinical Genetics (M.D.) | $71,095.26 |
| Brittany Murray | Boston, MA | Family | $60,390.47 |
| Melissa Lah | Indianapolis, IN | Clinical Molecular Genetics | $49,083.60 |
| Hope Northrup | Houston, TX | Clinical Genetics (M.D.) | $43,623.93 |
| Erika Vucko | Chicago, IL | Nurse Practitioner | $42,440.78 |
| Joseph Ray | Galveston, TX | Clinical Genetics (M.D.) | $41,829.29 |
| Allison Bannick | Grand Rapids, MI | Pediatrics (Nurse Practitioner) | $37,253.49 |
| Amarilis Sanchez Valle | Tampa, FL | Clinical Genetics (M.D.) | $32,532.68 |
Prescribed Palynziq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.